---
title: Monoclonal Antibodies Are About to Revolutionize Pathogen Treatment
description: Once a risky bet due to frequent development snags, monoclonal antibody therapies for infectious disease are now headed to the clinic at a record pace.
---

[Biopharma Thought Leadership Blog | AGC Biologics ](https://www.agcbio.com/biopharma-blog)

# [Monoclonal Antibodies Are About to Revolutionize Pathogen Treatment](https://www.agcbio.com/biopharma-blog/monoclonals-are-about-to-revolutionize-pathogen-treatment)

 Written by [Nick McDonald](https://www.agcbio.com/biopharma-blog/author/nick-mcdonald) | August 17, 2023 at 4:13 PM

[View full post](https://www.agcbio.com/biopharma-blog/monoclonals-are-about-to-revolutionize-pathogen-treatment)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Nick McDonald"
  },
  "dateModified" : "2026-03-16T23:08:04.700Z",
  "datePublished" : "2023-08-17T16:13:07Z",
  "headline" : "Monoclonal Antibodies Are About to Revolutionize Pathogen Treatment",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1200,
    "url" : "https://1924513.fs1.hubspotusercontent-na1.net/hubfs/1924513/Website_Images/production_site_077.jpg",
    "width" : 1800
  },
  "mainEntityOfPage" : "https://www.agcbio.com/biopharma-blog/monoclonals-are-about-to-revolutionize-pathogen-treatment",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Biopharma Thought Leadership Blog | AGC Biologics"
  }
}
```